Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Browse Other Projects on Experiment
Related Projects
Targeting the Hypoxic Response in Multiple Myeloma Cells Engrafted in the Bone Marrow
Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody...
Will vitamin D improve the health of patients with heart failure?
We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function...
How good are North American mosquitoes at spreading Zika virus?
Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...